Phase 3

Leuprolide Acetate

Sponsor:

Tolmar Inc.

Code:

NCT04906395

Conditions

Breast Cancer

Eligibility Criteria

Sex: All

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

TOL2506

Tamoxifen

Letrozole Tablets

Anastrozole Tablets

Exemestane Tablets

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by Tolmar Inc. on 2025-05-18.